Top-Searched Lab Tests
Explore Conditions
Explore Biomarkers
Explore Diagnostic Labs
New Lab Tests
| Test Name | Methodology | Specimen | TAT | Lab |
|---|---|---|---|---|
| DCISionRT | Immunoassay | Tumor Tissue | 3-5 d | PreludeDx |
| AlloHome | Other | Other | — | CareDx, Inc. |
| HeartCare | Composite | Plasma, Other | — | CareDx, Inc. |
| AlloSure Plus | Other | Whole Blood | 2-3 d | CareDx, Inc. |
| AlloSure Lung | NGS | Whole Blood | 3-5 d | CareDx, Inc. |
DCISionRT
Methodology:Immunoassay
Specimen:Tumor Tissue
TAT:3-5 d
Lab:PreludeDx
AlloHome
Methodology:Other
Specimen:Other
TAT:—
Lab:CareDx, Inc.
HeartCare
Methodology:Composite
Specimen:Plasma, Other
TAT:—
Lab:CareDx, Inc.
AlloSure Plus
Methodology:Other
Specimen:Whole Blood
TAT:2-3 d
Lab:CareDx, Inc.
AlloSure Lung
Methodology:NGS
Specimen:Whole Blood
TAT:3-5 d
Lab:CareDx, Inc.
Featured Companion Diagnostics
| Test Name | Methodology | Specimen | TAT | Lab |
|---|---|---|---|---|
| xT CDx | NGS | Tissue, Whole Blood, Saliva | 10-14 d | Tempus AI |
| Vysis Chronic Lymphocytic Leukemia (CLL) Panel | Chromosomal / Cytogenetics | Whole Blood, Bone Marrow | 5 d | MPLN |
| PD-L1 SP263 FDA for NSCLC | Immunoassay | Tissue | 1-2 d | NeoGenomics |
| PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD) | Chromosomal / Cytogenetics | Tumor Tissue | — | ARUP Laboratories |
| nAbCyte™ Anti‑AAVRh74var HB‑FE Assay (nAbCyte Assay) | Other | Serum | 7-10 d | Labcorp |
xT CDx
Methodology:NGS
Specimen:Tissue, Whole Blood, Saliva
TAT:10-14 d
Lab:Tempus AI
Vysis Chronic Lymphocytic Leukemia (CLL) Panel
Methodology:Chromosomal / Cytogenetics
Specimen:Whole Blood, Bone Marrow
TAT:5 d
Lab:MPLN
PD-L1 SP263 FDA for NSCLC
Methodology:Immunoassay
Specimen:Tissue
TAT:1-2 d
Lab:NeoGenomics
PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD)
Methodology:Chromosomal / Cytogenetics
Specimen:Tumor Tissue
TAT:—
Lab:ARUP Laboratories
nAbCyte™ Anti‑AAVRh74var HB‑FE Assay (nAbCyte Assay)
Methodology:Other
Specimen:Serum
TAT:7-10 d
Lab:Labcorp
Featured Sponsored Testing
| Program Name | Therapeutic Area(s) | Condition | Lab |
|---|---|---|---|
| Color Hereditary Cancer Test | Oncology | Ovarian Cancer, Uterine/Endometrial Cancer | Color Health |
| Early Stage Type 1 Diabetes Initial Screen | Endocrinology | Type 1 Diabetes | Revvity Omics, Inc. |
| Kyowa Kirin Sponsored Hypophosphatemia 13 Gene Panel | Endocrinology, Metabolic | X-linked Hypophosphatemia (XLH), Tumor-Induced Osteomalacia (TIO) | Invitae | Labcorp |
| NovoDETECT Primary Hyperoxaluria Panel | Nephrology | Primary Hyperoxaluria (PH) | Blueprint Genetics |
| TK2 Sequencing (single gene) | Neurology | Thymidine Kinase 2 Deficiency (TK2d) | Prevention Genetics |
Color Hereditary Cancer Test
Therapeutic Area(s):Oncology
Condition:Ovarian Cancer, Uterine/Endometrial Cancer
Lab:Color Health
Early Stage Type 1 Diabetes Initial Screen
Therapeutic Area(s):Endocrinology
Condition:Type 1 Diabetes
Lab:Revvity Omics, Inc.
Kyowa Kirin Sponsored Hypophosphatemia 13 Gene Panel
Therapeutic Area(s):Endocrinology, Metabolic
Condition:X-linked Hypophosphatemia (XLH), Tumor-Induced Osteomalacia (TIO)
Lab:Invitae | Labcorp
NovoDETECT Primary Hyperoxaluria Panel
Therapeutic Area(s):Nephrology
Condition:Primary Hyperoxaluria (PH)
Lab:Blueprint Genetics
TK2 Sequencing (single gene)
Therapeutic Area(s):Neurology
Condition:Thymidine Kinase 2 Deficiency (TK2d)
Lab:Prevention Genetics